Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

65 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
An evaluation of the impact of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable non-small-cell lung cancer.
Forrest LM, McMillan DC, McArdle CS, Dunlop DJ. Forrest LM, et al. Br J Cancer. 2005 Oct 31;93(9):977-8. doi: 10.1038/sj.bjc.6602825. Br J Cancer. 2005. PMID: 16234818 Free PMC article.
Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial.
Ferry D, Billingham L, Jarrett H, Dunlop D, Woll PJ, Nicolson M, Shah R, Thompson J, Spicer J, Muthukumar D, Skailes G, Leonard P, Chetiyawardana AD, Wells P, Lewanski C, Crosse B, Hill M, Gaunt P, O'Byrne K. Ferry D, et al. Eur J Cancer. 2017 Sep;83:302-312. doi: 10.1016/j.ejca.2017.05.037. Epub 2017 Aug 4. Eur J Cancer. 2017. PMID: 28780466 Free PMC article. Clinical Trial.
The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer.
Wakelee HA, Takimoto CH, Lopez-Anaya A, Chu Q, Middleton G, Dunlop D, Ramlau R, Leighl N, Rowinsky EK, Hao D, Zatloukal P, Jacobs CD, Rodon J. Wakelee HA, et al. Cancer Chemother Pharmacol. 2012 Feb;69(2):563-71. doi: 10.1007/s00280-011-1772-z. Epub 2011 Nov 6. Cancer Chemother Pharmacol. 2012. PMID: 22057855 Clinical Trial.
A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC).
Wakelee HA, Middleton G, Dunlop D, Ramlau R, Leighl N, Hao D, Lopez-Anaya A, Zatloukal P, Jacobs CD. Wakelee HA, et al. Cancer Chemother Pharmacol. 2012 Mar;69(3):815-24. doi: 10.1007/s00280-011-1771-0. Epub 2011 Nov 6. Cancer Chemother Pharmacol. 2012. PMID: 22057854 Clinical Trial.
Combination therapy with gefitinib and rofecoxib in patients with platinum-pretreated relapsed non small-cell lung cancer.
O'Byrne KJ, Danson S, Dunlop D, Botwood N, Taguchi F, Carbone D, Ranson M. O'Byrne KJ, et al. J Clin Oncol. 2007 Aug 1;25(22):3266-73. doi: 10.1200/JCO.2006.09.2791. J Clin Oncol. 2007. PMID: 17664473 Clinical Trial.
Phase II study of imatinib in patients with small cell lung cancer.
Johnson BE, Fischer T, Fischer B, Dunlop D, Rischin D, Silberman S, Kowalski MO, Sayles D, Dimitrijevic S, Fletcher C, Hornick J, Salgia R, Le Chevalier T. Johnson BE, et al. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5880-7. Clin Cancer Res. 2003. PMID: 14676110 Clinical Trial.
DHA-paclitaxel (Taxoprexin) as first-line treatment in patients with stage IIIB or IV non-small cell lung cancer: report of a phase II open-label multicenter trial.
Payne M, Ellis P, Dunlop D, Ranson M, Danson S, Schacter L, Talbot D. Payne M, et al. J Thorac Oncol. 2006 Nov;1(9):984-90. J Thorac Oncol. 2006. PMID: 17409983 Clinical Trial.
Comparative cost-minimisation of oral and intravenous chemotherapy for first-line treatment of non-small cell lung cancer in the UK NHS system.
Le Lay K, Myon E, Hill S, Riou-Franca L, Scott D, Sidhu M, Dunlop D, Launois R. Le Lay K, et al. Eur J Health Econ. 2007 Jun;8(2):145-51. doi: 10.1007/s10198-006-0034-1. Epub 2007 Feb 28. Eur J Health Econ. 2007. PMID: 17333088
65 results
Jump to page